SS Innovations, the trailblazer behind India’s groundbreaking SSI Mantra Surgical Robotic System, has reached a significant milestone in the field of medical science by becoming the inaugural company in India to obtain approval from the Central Drugs Standard Control Organization (CDSCO) for Telesurgery and Teleproctoring. This achievement is a massive step forward in surgical robotics.
This accolade distinguishes SSI Mantra as the inaugural surgical robotic system in India permitted to execute these advanced functions. It underlines SS Innovations’ dedication to propelling surgical technology forward, making sophisticated procedures more attainable, and bolstering India’s status as a leader in global healthcare innovation.
First conceived in the 1980s for potential use in space and remote combat zones, the concept of Telesurgery was fraught with obstacles due to early technological constraints and insufficient bandwidth. Today, with rapid advancements in technology and communication, SSI has actualized this vision with its revolutionary SSI Mantra Surgical Robotic System. By introducing Telesurgery and Teleproctoring, the system aspires to decentralize and broaden the reach of surgical expertise, addressing pressing healthcare disparities, especially in rural regions where specialized medical services have been scarce.
At the helm of this ground-breaking success is SS Innovations’ founder, chairman, and CEO, Dr. Sudhir Srivastava, who remarked, “Achieving this landmark with SSI Mantra underscores our ambition to revolutionize surgical methodology, improve access, and accelerate the integration of robotic surgery. With Telesurgery and Teleproctoring, a dream spanning over four decades has materialized. With the current technological capabilities and connectivity, we envision a genuine decentralization and democratization of surgical expertise, empowering both patients and surgeons in distant corners of India and worldwide. This transformation is a game-changer, especially in a country like ours, where many reside in smaller towns and rural locales. By enabling surgical interventions from afar, we are reshaping healthcare’s future.”
This pioneering accomplishment heralds a new era in India’s healthcare realm, with SSI at the forefront of advancing surgical practice through state-of-the-art technology. The approval for Telesurgery and Teleproctoring functions in the SSI Mantra Surgical Robotic Systems not only reflects the company’s commitment to innovation but also lays the groundwork for dependable, high-standard healthcare services throughout India and beyond. As SS Innovations continues to push the envelope in medical technology, it remains committed to transforming health services delivery, making cutting-edge treatments accessible, and enhancing patient lives globally.
SS Innovations, operating out of India, concentrates on developing, manufacturing, assembling, and promoting the SSi Mantra surgical robotic system. The company, registered with the United States SEC, is devoted to advancing medical robotics using advanced technology and partnerships with renowned surgeons.
The SSI Mantra Surgical Robotic System by SS Innovations is a versatile multi-arm setup featuring several advanced technological attributes. It supports the use of 3-5 robotic arms and includes an open-faced ergonomic Surgeon Command Centre, a 32-inch 3D 4K monitor, a 23-inch 2D Touch Panel for comprehensive patient data, a virtual portrayal of the robotic Patient Side Arm Carts, and capabilities for overlaying 3D anatomical models from diagnostic imaging. The Vision Cart offers the operating team the same magnified 3D 4K perspective as the surgeon, improving safety and operational efficiency.